Preview this article 1 min The dispute centers on prescription drug claims between 2020 and 2022. Charter alleges the ...

Add Yahoo as a preferred source to see more of our stories on Google. Two dozen Democrat and Republican lawmakers have raised issues about Express Scripts, the company that oversees the U.S.

Express Scripts Inc. knows what it means to be a good neighbor, and they have proven that with $4 million in gifts to the University of Missouri-St. Louis since announcing in 2005 that the company was ...

If you've spent years managing your health across MyChart, Express Scripts, and WellCare, you know the frustration of disjointed alerts and opaque prior authorization processes. But as of May 2026, ...

Add Yahoo as a preferred source to see more of our stories on Google. FRANKFORT, Ky. (AP) — Kentucky’s attorney general has sued Express Scripts, claiming the big pharmacy benefit manager was at the ...

If you've been relying on Express Scripts for your 90-day refills and home delivery, 2026 brings a critical shift: a new 'Copay Assurance' program that caps out-of-pocket costs, paired with stricter ...

ST. LOUIS — Supermarket operators are preparing for an uptick in pharmacy business as Walgreens was scheduled to end its contract with pharmacy benefits manager Express Scripts on Jan. 1. "Many ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "The fact is that in the unlikely event the ...

Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group is aiming to expand access to health care in rural communities through partnerships with ...

On the heels of a similar announcement from Optum Rx, pharmacy benefit management giant Express Scripts said Monday that it will add three biosimilars to its formulary to compete with Humira. The PBM ...

Express Scripts, the pharmacy benefits management business of the Cigna Group's Evernorth, will add three additional biosimilars to its National Preferred Formulary that it said will compete with ...